Thrombectomy Devices Market Overview:
Global Thrombectomy Devices Market was valued at $982 million in 2016, and is expected to reach $1,389 million by 2022, supported by a CAGR of 5.9% during the forecast period 2014 - 2022. Thrombectomy devices are used to treat blood clots present in the arteries, veins, and capillaries.
These are carefully designed to minimize damage to the vessel wall during a procedure, with the minimum blood loss. They are available in different sizes and diameters, and depending on the affected area, the required catheter is chosen. These devices are used to treat acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis conditions.
PREVALENCE OF PERIPHERAL ARTERIAL DISEASE (PAD) BY AGE
This is attributed by the increase in the incidence of chronic diseases due to the sedentary lifestyle, and unhealthy living conditions and habits in the current generation. Also, the rise in the geriatric population has led to increase in the incidence of cardiovascular diseases, which will be one of the growth factors of the thrombectomy devices market. The growth in demand for minimally invasive procedures, and better healthcare infrastructure along with the increase in the competition, has led to technological advancements and innovations. These factors will further drive the market of thrombectomy devices. However, lack of trained professionals and complicated use of these devices restrict the market growth. In addition, deep vein thrombosis and pulmonary embolism sometimes remain underdiagnosed and can lead to serious health conditions, which can only be avoided by escaping the sedentary lifestyle and creating awareness among all.
Global Thrombectomy Devices Market Segmentation
The report covers the analysis of thrombectomy devices market based on five categories‐technology, type, utility, diseases, and geography. Based on the technology used, the market is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, and rheolytic thrombectomy devices. Based on type, the market is divided into two segments‐advanced devices and manual devices. On the basis of utility of devices, the market is classified into reusable devices and disposable devices. The thrombectomy devices market is segmented into three types of diseases‐peripheral diseases, coronary diseases, and neuro diseases. Based on geography, the thrombectomy devices market is studied with respect to four major regions‐North America (U.S., Canada, and Mexico); Europe (Germany, France, U.K., Italy, Spain, and Others); Asia-Pacific (Japan, China, India, Australia, and Others); and LAMEA (Brazil, U.A.E, South Africa, and Others). The report includes the revenue generated from the sales of these aforementioned categories.
Key players have adopted product launch and mergers & acquisitions as their key development strategies. For instance, on September 2015, Medtronic acquired Lazarus Effect to strengthen its market of clot removal devices effective during ischemic stroke. Also, market leader Boston Scientific received FDA approval and CE mark for its thrombectomy product line called AngioJet ZelanteDVT Thrombectomy Catheter on November 2015. This has helped Boston Scientific to continue to be the leading innovator for peripheral vascular disease in the industry, and expanded their product portfolio and sales force across various geographies.
The key players profiled in this report include Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, Penumbra Inc., The Spectranetics Corporation, AngioDynamics, Inc., Terumo Corporation, Johnson and Johnson, Inc., Stryker Corporation, and Vascular Solutions, Inc.
Thrombectomy Devices Market Revenue, By Technology
Mechanical thrombectomy devices was the highest revenue-generating segment in 2015 followed by aspiration and rheolytic thrombectomy devices. This is attributed by the fact that mechanical thrombectomy has the highest usage amongst the three technologies available. Also, they are able to deliver better results especially in the ischemic stroke cases. However, market for rheolytic thrombectomy devices will grow faster than mechanical thrombectomy devices owing to the fact that the technological advancements are adopted for more efficient results. Also, the growth in incidences of peripheral and coronary diseases will drive the market for rheolytic thrombectomy devices.
INDIA THROMBECTOMY DEVICES MARKET, 2014‐2022 ($MILLION)
The Indian thrombectomy devices market is projected to grow at a CAGR of 11.4% during forecast period. This growth can be attributed to the development of R&D, increased number of aged population, and high prevalence of PAD. Penumbra System launched its first mechanical thrombectomy device approved by Drug Control General of India to treat acute ischemic stroke. The devices launched in India are Trevo Stent Retriever, product by Stryker and Solitaire Stent Retriever System by Medtronic used for revascularization. Teleflex Incorporated present as Teleflex Medical India, Medtronic and Stryker are key vendors of thrombectomy device market in India.
THROMBECTOMY DEVICES MARKET KEY BENEFITS FOR STAKEHOLDERS
- The Global thrombectomy report provides an extensive analysis of the current market trends and future estimations of the market.
- The market scenario is comprehensively analyzed with respect to the technology, type, utility, and disease.
- The market estimations in this report are based on high-end analysis of the key developments for 2014‐2022.
- Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.
- In-depth analysis of the market based on geography gives an understanding of the regional market, which assists in strategic business planning.
THROMBECTOMY DEVICES MARKET KEY SEGMENTS
The Global thrombectomy devices market segmentation is illustrated as follows:
- Mechanical Thrombectomy Devices
- Aspiration Thrombectomy Devices
- Rheolytic Thrombectomy Devices
- Automated Devices
- Manual Devices
- Reusable Devices
- Disposable Devices
- Peripheral Diseases
- Coronary Diseases
- Neural Diseases
- North America
- Saudi Arabia
- South Africa